Craft

Simris Group

Stock Price

KR0.1

2024-10-29

Market Capitalization

KR28.5 M

2024-10-29

Revenue

KR1.6 M

FY, 2025

Simris Group Summary

Company Summary

Overview
Simris Group is a biotechnology company that develops and manufactures ADC payloads for cancer treatment. It specializes in cyanobacterial science and conjugation methods, and focuses on researching microcystin toxin variants that target both hematologic and solid tumors.
Type
Public
Status
Active
Founded
2011
HQ
Hammenhög, SE | view all locations
Website
https://simrisgroup.com
Cybersecurity rating
Sectors

LocationsView all

2 locations detected

  • Hammenhög, Skåne län HQ

    Sweden

    Herrestadsvägen 24a

  • Berlin, BE

    Germany

    Magnusstraße 11

Simris Group Financials

Summary Financials

Revenue (FY, 2025)
kr1.6M
Gross profit (FY, 2025)
kr3.5M
Net income (FY, 2025)
(kr26.8M)
Cash (FY, 2025)
kr1.5M
EBIT (FY, 2025)
(kr29.6M)
Enterprise value
$49.5M

Footer menu